Woodward Diversified Capital’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
Other funds holding BMY
AIM
FWIA
Woodward Diversified Capital's BMY Position: Q2 2026 in Review
Woodward Diversified Capital held its Bristol-Myers Squibb (BMY) position steady in Q2 2026 at 3,744 shares worth $216K. The position accounts for 0.1% of the portfolio, ranked #167.
Woodward Diversified Capital first reported a position in BMY in Q4 2020 and has held it in 17 quarters since. The position peaked at $893K in Q2 2022. 1,158 funds tracked by Wall St. Rank hold BMY as of Q2 2026.
- Woodward Diversified Capital held 3,744 shares of Bristol-Myers Squibb worth $216K as of Q2 2026.
- Woodward Diversified Capital left its Bristol-Myers Squibb share count unchanged in Q2 2026.
- Bristol-Myers Squibb made up 0.1% of Woodward Diversified Capital's portfolio in Q2 2026, its #167 holding.
- Woodward Diversified Capital first reported a position in Bristol-Myers Squibb in Q4 2020 and has held it in 17 quarters since.
- Woodward Diversified Capital's Bristol-Myers Squibb position peaked at $893K in Q2 2022.
- 1,158 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q2 2026.
Based on Woodward Diversified Capital's 13F filing for Q2 2026, filed 28 Jul 2026.